scholarly journals Iron and Early Brain Injury after Subarachnoid Hemorrhage

2010 ◽  
Vol 30 (11) ◽  
pp. 1791-1792 ◽  
Author(s):  
Matthew C Loftspring

Aneurysmal subarachnoid hemorrhage (SAH) affects approximately 27,000 Americans per year. Although delayed cerebral vasospasm is of high clinical significance, mortality within the first 2 days may approach 30%. In this issue of the Journal of Cerebral Blood Flow and Metabolism, Lee et al have studied the role of iron in early brain injury after experimental SAH. They found that iron chelation with deferoxamine reduced mortality and oxidative DNA damage, and lessened the induction of iron-handling proteins. Taken together, these results highlight the deleterious potential of blood breakdown products and provide an insight into future intervention.

2015 ◽  
Vol 157 (5) ◽  
pp. 781-792 ◽  
Author(s):  
Ji-Yang An ◽  
Li-Li Zhou ◽  
Peng Sun ◽  
Hong-Gang Pang ◽  
Dan-Dong Li ◽  
...  

2017 ◽  
Vol 8 ◽  
Author(s):  
Laurent Carteron ◽  
Camille Patet ◽  
Daria Solari ◽  
Mahmoud Messerer ◽  
Roy T. Daniel ◽  
...  

Stroke ◽  
2009 ◽  
Vol 40 (7) ◽  
pp. 2519-2525 ◽  
Author(s):  
Takumi Sozen ◽  
Reiko Tsuchiyama ◽  
Yu Hasegawa ◽  
Hidenori Suzuki ◽  
Vikram Jadhav ◽  
...  

2021 ◽  
Vol 12 ◽  
Author(s):  
Lingxin Cai ◽  
Hanhai Zeng ◽  
Xiaoxiao Tan ◽  
Xinyan Wu ◽  
Cong Qian ◽  
...  

Aneurysmal subarachnoid hemorrhage (aSAH) is an important type of stroke with the highest rates of mortality and disability. Recent evidence indicates that neuroinflammation plays a critical role in both early brain injury and delayed neural deterioration after aSAH, contributing to unfavorable outcomes. The neutrophil-to-lymphocyte ratio (NLR) is a peripheral biomarker that conveys information about the inflammatory burden in terms of both innate and adaptive immunity. This review summarizes relevant studies that associate the NLR with aSAH to evaluate whether the NLR can predict outcomes and serve as an effective biomarker for clinical management. We found that increased NLR is valuable in predicting the clinical outcome of aSAH patients and is related to the risk of complications such as delayed cerebral ischemia (DCI) or rebleeding. Combined with other indicators, the NLR provides improved accuracy for predicting prognosis to stratify patients into different risk categories. The underlying pathophysiology is highlighted to identify new potential targets for neuroprotection and to develop novel therapeutic strategies.


Sign in / Sign up

Export Citation Format

Share Document